BLOOMBERG – Twenty-eight people developed blood clots with low platelets after receiving Johnson & Johnson’s Covid-19 vaccine, according to the Centers for Disease Control and Prevention.
The 28 cases were identified out of 8.7 million doses of J&J’s vaccine administered in the U.S., the CDC said in a presentation posted online Wednesday.
On May 11, the CDC said on its website tracking the latest cases that the known potential benefits of the vaccine continued to outweigh its potential risks.
All 28 confirmed cases occurred before the pause began on April 13, according to the new presentation. The median age of patients was 40 and their ages ranged from 18 to 59. Of the 28 cases, 22 occurred in women and six occurred in men.
Nineteen of the total cases involved a specific type of clot found in the brain. Obesity was the most common risk factor. Three of the people died, four remain hospitalized, two were discharged to a post-acute care facility and 19 were sent home … Click here to read more.
By Deidre McPhillips and Maggie Fox, CNN, May 12, 2021:
Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine
CNN – The risk of dying from Covid-19 is 40 times the risk of developing a rare blood clotting condition after getting the Johnson & Johnson vaccine, a CNN analysis shows.
The US Centers for Disease Control and Prevention said Wednesday it has received reports of 28 people who have developed a rare blood clotting syndrome out of 8.7 million given J&J’s Janssen coronavirus vaccine.
However, in that same time period — March 2 to May 7 — more than 2.2 million people were diagnosed with Covid-19 and more than 43,000 died, according to data from Johns Hopkins University.
In a group of about 8.7 million people, that scales to nearly 59,000 new Covid-19 cases reported in the past two months and nearly 1,150 new Covid-19 deaths, more than 40 times the number of reported and confirmed cases of TTS … Click here to read more.
